795
Views
14
CrossRef citations to date
0
Altmetric
Report

Glycogen synthase kinase 3 β activity is required for hBora/Aurora A-mediated mitotic entry

, , , , &
Pages 953-960 | Published online: 26 Feb 2013

References

  • Nurse P. Universal control mechanism regulating onset of M-phase. Nature 1990; 344:503 - 8; http://dx.doi.org/10.1038/344503a0; PMID: 2138713
  • Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008; 320:1655 - 8; http://dx.doi.org/10.1126/science.1157425; PMID: 18566290
  • Macůrek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455:119 - 23; http://dx.doi.org/10.1038/nature07185; PMID: 18615013
  • van Vugt MA, Medema RH. Getting in and out of mitosis with Polo-like kinase-1. Oncogene 2005; 24:2844 - 59; http://dx.doi.org/10.1038/sj.onc.1208617; PMID: 15838519
  • Watanabe N, Arai H, Nishihara Y, Taniguchi M, Watanabe N, Hunter T, et al. M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci USA 2004; 101:4419 - 24; http://dx.doi.org/10.1073/pnas.0307700101; PMID: 15070733
  • Seki A, Coppinger JA, Du H, Jang CY, Yates JR 3rd, Fang G. Plk1- and beta-TrCP-dependent degradation of Bora controls mitotic progression. J Cell Biol 2008; 181:65 - 78; http://dx.doi.org/10.1083/jcb.200712027; PMID: 18378770
  • Chan EH, Santamaria A, Silljé HH, Nigg EA. Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora. Chromosoma 2008; 117:457 - 69; http://dx.doi.org/10.1007/s00412-008-0165-5; PMID: 18521620
  • Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007; 64:1930 - 44; http://dx.doi.org/10.1007/s00018-007-7045-7; PMID: 17530463
  • Takahashi-Yanaga F, Sasaguri T. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 2008; 20:581 - 9; http://dx.doi.org/10.1016/j.cellsig.2007.10.018; PMID: 18023328
  • Wakefield JG, Stephens DJ, Tavaré JM. A role for glycogen synthase kinase-3 in mitotic spindle dynamics and chromosome alignment. J Cell Sci 2003; 116:637 - 46; http://dx.doi.org/10.1242/jcs.00273; PMID: 12538764
  • Ciani L, Krylova O, Smalley MJ, Dale TC, Salinas PC. A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules. J Cell Biol 2004; 164:243 - 53; http://dx.doi.org/10.1083/jcb.200309096; PMID: 14734535
  • Tighe A, Ray-Sinha A, Staples OD, Taylor SS. GSK-3 inhibitors induce chromosome instability. BMC Cell Biol 2007; 8:34; http://dx.doi.org/10.1186/1471-2121-8-34; PMID: 17697341
  • Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr., Hemmings BA, et al. GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS ONE 2009; 4:e7443; http://dx.doi.org/10.1371/journal.pone.0007443; PMID: 19823589
  • Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. J Neurooncol 2011; 104:145 - 53; http://dx.doi.org/10.1007/s11060-010-0491-3; PMID: 21161565
  • Pizarro JG, Folch J, Esparza JL, Jordan J, Pallàs M, Camins A. A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286. J Cell Mol Med 2009; 13:9B 3906 - 17; http://dx.doi.org/10.1111/j.1582-4934.2008.00389.x; PMID: 18624766
  • Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1992; 1114:147 - 62; PMID: 1333807
  • Lee J, Kim MS. The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 2007; 77:Suppl 1 S49 - 57; http://dx.doi.org/10.1016/j.diabres.2007.01.033; PMID: 17478001
  • Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer’s disease. J Neurochem 2008; 104:1433 - 9; http://dx.doi.org/10.1111/j.1471-4159.2007.05194.x; PMID: 18088381
  • Raina AK, Monteiro MJ, McShea A, Smith MA. The role of cell cycle-mediated events in Alzheimer’s disease. Int J Exp Pathol 1999; 80:71 - 6; http://dx.doi.org/10.1046/j.1365-2613.1999.00106.x; PMID: 10469261
  • Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain. J Neurosci 1997; 17:3588 - 98; PMID: 9133382
  • Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68:850 - 8; http://dx.doi.org/10.1021/ac950914h; PMID: 8779443
  • Hoffmann R, Metzger S, Spengler B, Otvos L Jr.. Sequencing of peptides phosphorylated on serines and threonines by post-source decay in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mass Spectrom 1999; 34:1195 - 204; http://dx.doi.org/10.1002/(SICI)1096-9888(199911)34:11<1195::AID-JMS881>3.0.CO;2-C; PMID: 10548813
  • Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J Biol Chem 2002; 277:2381 - 4; http://dx.doi.org/10.1074/jbc.C100228200; PMID: 11723108

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.